All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective second-line therapies.
Radon exposure associated with concerning rise in non-smoking lung cancer
Although lung cancer is traditionally thought of as a “smoker’s disease,” a surprising 15-20% of newly diagnosed lung cancers occur in people who have never